Progesterone receptor status and tumor grade predict the 21-gene recurrence score of invasive lobular breast cancer.
Conclusion: The 21-gene RS testing may not be necessary for patients with PR+/G1-2 ILC.
PMID: 31234641 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Epidemiology | Genetics | Internal Medicine | Lobular Carcinoma | Undifferentiated Carcinoma